These observations also explain the pro- or antitumoral effects described for IL-23 on NK cells (29, 40–42, 47, 48), which may critically depend on the composition of the tumor microenvironment, in particular, the presence of other cytokines that regulate NK cell effector functions. The gene discussed is IL23A; the disease is neoplasm.